Takeshi Yoshida

Takeshi Yoshida

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2011 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
ABAnna De Benedetto
Anna De Benedetto
NRNicholas M. Rafaels
Nicholas M. Rafaels
LMLaura Y. McGirt
Laura Y. McGirt
AIAndrei I. Ivanov
Andrei I. Ivanov
SGSteve N. Georas
Steve N. Georas
LBLisa A. Beck
Lisa A. Beck

1 February 2013 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
IKI-Hsin Kuo
I-Hsin Kuo
TYTakeshi Yoshida
Takeshi Yoshida
ABAnna De Benedetto
Anna De Benedetto
LBLisa A. Beck
Lisa A. Beck

1 October 2018 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
ESEric L. Simpson
Eric L. Simpson
MVMiguel Villarreal
Miguel Villarreal
BJBrett Jepson
Brett Jepson
NRNick Rafaels
Nick Rafaels
GDGloria David
Gloria David
LBLisa A. Beck
Lisa A. Beck

11 November 2014 in Tissue Barriers
Verified
Journal Article
Open access
JBJm Brandner
Jm Brandner
MZM Zorn-Kruppa
M Zorn-Kruppa
TYTakeshi Yoshida
Takeshi Yoshida
IMI Moll
I Moll
LBLA Beck
LA Beck
ABAnna De Benedetto
Anna De Benedetto
The skin, the largest organ of the body, is an essential barrier that under homeostatic conditions efficiently protects and/or minimizes damage from both environmental (e.g. microorganisms, physical trauma, ultraviolet radiation) and endogenous (e.g., cancers, inflammation) factors. This formidable barrier function resides mainly in the epidermis, a dynamic, highly-stratified epithelium. The epidermis has 2 major barrier structures: stratum corneum, the outmost layer and tight junctions, intercellular junctions that seal adjacent keratinocytes in the stratum granulosum, found below the stratum corneum.In recent years there have been significant advances in our understanding of tight junction function, composition and regulation. Herein we review what is known about tight junctions in healthy skin and keratinocyte culture systems and highlight the dynamic crosstalk observed between tight junctions and the cutaneous immune system. Finally we discuss the preliminary observations suggesting that tight junctio...

1 April 2013 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
IKI-Hsin Kuo
I-Hsin Kuo
ACAmanda Carpenter-Mendini
Amanda Carpenter-Mendini
TYTakeshi Yoshida
Takeshi Yoshida
LMLaura Y. McGirt
Laura Y. McGirt
AIAndrei I. Ivanov
Andrei I. Ivanov
LBLisa A. Beck
Lisa A. Beck

1 June 2006 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
TYTakeshi Yoshida
Takeshi Yoshida
LQLing Qin
Ling Qin
LELinda A. Egger
Linda A. Egger
MIMasayori Inouye
Masayori Inouye
The ompF and ompC genes of Escherichia coli are reciprocally regulated by a single transcription factor, phosphorylated OmpR (OmpR-P), depending upon medium osmolarity. This regulation involves activation of ompF and its repression with concomitant activation of ompC. This occurs through OmpR-P binding to four (F1, F2, F3, and F4) and three (C1, C2, and C3) sites located upstream of the ompF and ompC promoters, respectively, through a novel mechanism. Here we show that there is a distinct OmpR-P binding hierarchy within F1, F2, and F3 sites as well as within C1, C2, and C3 sites. Each of these sites contains two tandem 10-bp OmpR-P-binding subsites, a-site and b-site (from 5′ to 3′ direction). OmpR-P has higher affinity to the downstream b-site than to the upstream a-site in each case. Six OmpR-P molecules bind to F and C sites two-by-two in a discontinuous “galloping” manner. We propose that this tight hierarchical binding of a transcription factor, OmpR, allows distinct stepwise regulation of ompF and ompC transcription, which minimizes their overlapping expression upon changes in the medium osmolarity to achieve the reciprocal expression of ompF and ompC.